ORI Q1 2026 Earnings EPS Misses Estimates as Operating Environment Challenges Persist PLRX Q1 2026 Earnings Narrowerthanexpected Loss Highlights Clinical Pipeline Progress MP Materials Q1 2026 Earnings EPS Surprise Triggers Sharp Rally GLAD Q1 2026 Earnings EPS Misses Estimates Shares Rise Despite 2057 Surprise OXM Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Gain Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress